Acriptega 50mg/300mg/300mg – 90 Tablets
Antiretroviral Therapy • Dolutegravir + Lamivudine + Tenofovir • HIV-1 Treatment
Acriptega is a once-daily fixed-dose combination antiretroviral medicine used in the management of HIV-1 infection. It combines three active ingredients — Dolutegravir (50mg), Lamivudine (300mg), and Tenofovir Disoproxil Fumarate (300mg) — to effectively suppress viral replication, reduce viral load, and help maintain immune function.
Active Ingredients
- Dolutegravir 50mg
- Lamivudine 300mg
- Tenofovir Disoproxil Fumarate 300mg
Indications
- Treatment of HIV-1 infection in adults and adolescents (as prescribed)
- Part of combination antiretroviral therapy (ART)
Benefits
- Helps lower HIV viral load
- Supports improvement of CD4 cell count
- Convenient once-daily dosing
- Fixed-dose combination simplifies treatment regimen
Dosage & Administration
- Take exactly as prescribed by a qualified healthcare professional.
- Usually taken once daily.
- Swallow the tablet whole with water.
- Do not skip doses to maintain viral suppression.
Possible Side Effects
- Headache
- Nausea
- Insomnia
- Dizziness
- Fatigue
Precautions
- Prescription-only medication.
- Regular medical monitoring is required.
- Inform your doctor of any kidney, liver, or bone conditions.
- Do not discontinue without medical advice.
- Keep out of reach of children.
Storage
Store in a cool, dry place below recommended room temperature. Keep the bottle tightly closed.
Important Note
Acriptega 50mg/300mg/300mg does not cure HIV but helps control the infection when taken consistently under medical supervision.